These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 11369802)

  • 1. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice.
    Kawashiri M; Zhang Y; Usher D; Reilly M; Puré E; Rader DJ
    J Lipid Res; 2001 Jun; 42(6):943-50. PubMed ID: 11369802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
    Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
    Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
    Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
    Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.
    Tsukamoto K; Hiester KG; Smith P; Usher DC; Glick JM; Rader DJ
    J Lipid Res; 1997 Sep; 38(9):1869-76. PubMed ID: 9323596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor.
    Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N
    Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.
    Tangirala RK; Praticó D; FitzGerald GA; Chun S; Tsukamoto K; Maugeais C; Usher DC; Puré E; Rader DJ
    J Biol Chem; 2001 Jan; 276(1):261-6. PubMed ID: 11024044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice.
    Murayama T; Yokode M; Horiuchi H; Yoshida H; Sano H; Kita T
    Atherosclerosis; 2000 Dec; 153(2):295-302. PubMed ID: 11164418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
    Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
    J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
    Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
    Véniant MM; Withycombe S; Young SG
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1567-70. PubMed ID: 11597927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE.
    van Dijk KW; van Vlijmen BJ; van't Hof HB; van der Zee A; Santamarina-Fojo S; van Berkel TJ; Havekes LM; Hofker MH
    J Lipid Res; 1999 Feb; 40(2):336-44. PubMed ID: 9925664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice.
    Kirk EA; Sutherland P; Wang SA; Chait A; LeBoeuf RC
    J Nutr; 1998 Jun; 128(6):954-9. PubMed ID: 9614153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.
    Espirito Santo SM; Pires NM; Boesten LS; Gerritsen G; Bovenschen N; van Dijk KW; Jukema JW; Princen HM; Bensadoun A; Li WP; Herz J; Havekes LM; van Vlijmen BJ
    Blood; 2004 May; 103(10):3777-82. PubMed ID: 14739216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice.
    Ryu SK; King TJ; Fujioka K; Pattison J; Pashkow FJ; Tsimikas S
    Atherosclerosis; 2012 May; 222(1):99-105. PubMed ID: 22406426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.
    Aiello RJ; Brees D; Bourassa PA; Royer L; Lindsey S; Coskran T; Haghpassand M; Francone OL
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):630-7. PubMed ID: 11950702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
    Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.